Obsidian Therapeutics Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Obsidian Therapeutics Inc.
Former names
Gazelle Parent, Inc.
Ownership
Public
Status
Active
SIC code
2834 — Pharmaceutical Preparations
Headquarters city
Cambridge
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
OBX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002130606
EIN
42-1977778

Board of directors

Follow this board

Chief executives

Madan Jagasia · Chief Executive Officer
Since August 2026

Board connections

4 of this board's directors also sit on 4 other boards.

Network of Obsidian Therapeutics Inc.'s board connections CRISPR Therapeutics AG CRISPR Therapeutics AG Revvity Inc. Revvity Inc. Vericel Corporation Vericel Corporation Xilio Therapeutics Inc. Xilio Therapeutics Inc... Heidi Hagen Heidi Hagen Maria Fardis Maria Fardis Peter Barrett Peter Barrett Robert W. Ross Robert W. Ross Obsidian Therapeutics Inc.
Shared director Other board Same sector

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.